Mimedx (MDXG) EBT Margin (2011 - 2026)

Mimedx (MDXG) reported EBT Margin of 25.99% for Q1 2026, down 3575.0% on a YoY basis from 0.75% in Q1 2025, and down 240.82% sequentially from 18.46% in Q4 2025.

Mimedx (MDXG) EBT Margin (2011 - 2026) Analysis & Trends

Mimedx (MDXG) has 16 years of EBT Margin data on file, last reported at 25.99% in Q1 2026.

  • For the quarter ending Q1 2026, EBT Margin fell 3575.0% year-over-year to 25.99%; the trailing twelve-month figure through Mar 2026 stood at 10.87% (down 460.0% YoY), and the FY2025 full-year result was 15.83%, down 59.0% from the prior year.
  • EBT Margin retreated to 25.99% in Q1 2026, from 18.46% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 26.62% in Q2 2024 to a low of 25.99% in Q1 2026.
  • A 5-year average of 6.15% and a median of 12.11% in 2024 frame the typical range for EBT Margin.
  • Across the five-year window, EBT Margin jumped 2745 bps in 2023 and plunged 3575 bps in 2026, its largest moves.
  • Tracing MDXG's EBT Margin over 5 years: stood at 13.25% in 2022, then climbed by 21 bps to 16.02% in 2023, then fell by 24 bps to 12.11% in 2024, then jumped by 52 bps to 18.46% in 2025, then tumbled by 241 bps to 25.99% in 2026.
  • Business Quant data shows MDXG's EBT Margin at 25.99% in Q1 2026, 18.46% in Q4 2025, and 20.09% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Mimedx 615.09 Mn 455.31 Mn 41.62 Mn -25.99%

Historic Data

Download Data
DateValue
Mar 31, 2026 -25.99%
Dec 31, 2025 18.46%
Sep 30, 2025 20.09%
Jun 30, 2025 13.19%
Mar 31, 2025 9.76%
Dec 31, 2024 12.11%
Sep 30, 2024 13.58%
Jun 30, 2024 26.62%
Mar 31, 2024 13.47%
Dec 31, 2023 16.02%
Sep 30, 2023 11.54%
Jun 30, 2023 11.29%
Mar 31, 2023 -2.64%
Dec 31, 2022 13.25%
Sep 30, 2022 -12.37%
Jun 30, 2022 -16.16%
Mar 31, 2022 -17.70%
Dec 31, 2021 0.18%
Sep 30, 2021 -3.23%
Jun 30, 2021 -2.62%